DEVELOPMENT OF DELAYED RELEASE CAPSULES CONTAINING ENTERIC COATED MINI-TABLETS OF ESOMEPRAZOLE Authors: Sarvil K. Patel , PATEL AP AND PATEL JK
ABSTRACT
Now a day’s innovative dosage forms like mini-tablets which having diameter ? 3mm attaining
more eminence due to their simplicity of manufacturing and effective way of drug release
mechanisms. They are more effective and patient friendly dosage forms than conventional
dosage forms like tablets/capsules due to smaller size. They are manufactured just by
modification in compression step using application of multi-tips tooling. Even they are more
economical compare to complex and delicate pellets manufacturing process. Primary study
shows that esomeprazole accomplishes better and more sustained acid control than other proton
pump inhibitors but major problems accompanying are rapid degradation in gastric acid, BCS
class III drug, short biological half-life and wide inter-intra individual variability in the
bioavailability (50-90%) due to its low permeability. Enteric coated mini-tablets dosage form
serves as promising approach as they can protect the drug substance from degradation in gastric
media and avoids premature drug release due to smaller size, rapid transit time, higher surface
area and higher dispersability in gastro-intestinal tract which leads to improved drug absorption
compare to conventional dosage forms. Esomeprazole mini-tablets are manufactured using direct compression technique and further evaluated for optimization of barrier coat and enteric coat
using different types and levels of polymers to prepare robust and effective delayed release minitablets of esomeprazole.
Keywords: Direct compression, Multi-tips tooling, Barrier coat optimization, Enteric
coating polymers Publication date: 01/07/2022 https://ijbpas.com/pdf/2022/July/MS_IJBPAS_2022_6249.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.7.6249